obinutuzumab
Ligand Summary
anti-CD20 mAb for treating B-cell lymphoid cancers
ChEMBL: CHEMBL1743048
DrugCentral: 4983
LyCHI: obinutuzumab
Target Activities
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
ANTIBODY BINDING | ||||||